Although systemic sclerosis (SSc) is currently incurable, there have been recent advances in treatment. This review article begins by providing a brief background to SSc terms of disease subtyping and autoantibodies, because both predict trajectory help clinicians select appropriate monitoring treatment protocols. Broad principles management are then described: ‘disease-modifying’ therapies dir...
